483 Response Oxarc Jan 2018

Christopher Czajka FDA$119.00 - Available Now

FDA investigators audited the Oxarc - Pasco, WA, United States facility and issued inspectional observation (via FDA 483) on 11 Jan 2018.

Product details

  • Category:
  • Inspection end: 11 Jan 2018
  • Location: Pasco, United States
  • FEI: 3011682
Add To Cart